Pharma & Healthcare Quarterly Reports

Business Monitor International (BMI) has published a range of Pharmaceuticals & Healthcare Country reports for professionals doing business in pharmaceuticals and healthcare markets.

Each report features BMI's independent 5-year forecasts for drug and health expenditure, imports and exports, focusing on the growth outlook for the prescription, OTC, patented drugs and generics market segments.

The regulatory and reimbursements regime, intellectual property rights issues, epidemology, the long-term disease burden and domestic R&D are analysed, as well as the biotech and medical devices sectors. The reports also feature profiles of leading pharmaceuticals companies, covering SWOT analysis, product portfolio, latest financials and key developments.

Pharma & Healthcare Special Reports

BMI Special Reports, are a series of ad hoc industry and country reports.

The Country Special Reports focus on key economic events and our key proprietary views which are either global in nature or implication. In contrast Industry Special Reports provide in-depth granular analysis of key industry and market events and issues.

Multinational Pharmaceuticals & Healthcare Companies Directories

BMI's range of Multinational Pharmaceuticals & Healthcare Companies in Emerging Markets directories contain the latest available, fully researched data on over 99,000 senior executive contacts at over 28,000 leading American, European, Middle-Eastern, African and Asian multinational Pharmaceuticals & Healthcare companies in key emerging markets.

They are a powerful, cost-effective business development and research tool allowing you to immediately source, select and browse with an unlimited facility to export, multinational contacts and Pharmaceuticals & Healthcare companies in emerging markets.

The directories are a must-have marketing tool for all executives conducting business in the emerging markets, providing sales and marketing leads to secure new customers, partners or suppliers. They are ideal for market assessment and planning, as well as benchmarking and analysing your competitors.

Pharmaceuticals & Healthcare Competitive Intelligence Reports

BMI's range of Pharmaceuticals & Healthcare Competitive Intelligence Reports are an essential resource for manufacturers, investors and suppliers analysing and comparing the strategies adopted by major players as they seek to exploit opportunities and mitigate risks in a rapidly changing environment.

BMI assesses the competitive landscape, the market attractiveness for investors and profiles the leading players in Pharmaceuticals & Healthcare in key emerging markets.